Journal profile

International journal of nanomedicine

Publisher: DOVE Medical Press
ISSN1176-9114 | 1178-2013 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.88
Citation rate 9.58 11,407 total citations
h5-index 91 h5 depth signal
Cited share 93.2% 1,130 of 1,212
Total citations 11,407 Citation footprint
Metric signal 11.44 External metric anchor
Self-citation 3.8% 435 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 4,099
United States 562
South Korea 299
Saudi Arabia 249
India 216

Citing Fields of Research

Drug Delivery Systems 2,919
Nanoparticles 2,411
Polymer & Macromolecule Science 1,137
Immunology 544
Nanofibers, Scaffolds & Fabrication 506

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 9,512 Articles tracked across the journal lifetime
Indexed publication set 1,212 1,130 cited publications
Last 12 months 871 72.6 publications/month
Open access share 100.0% 871 OA publications in the last year
Leading citing country China 4,099 citing publications
Leading citing field Drug Delivery Systems 2,919 citing publications
Latest tracked publication 1 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, 2006-
PubMed
v1n1, 2006-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Drug Delivery Systems Nanoparticles Noncoding RNA Immunology Polymer & Macromolecule Science

Issuing & Sponsoring Bodies

Contributor
Institute of Nanotechnology

Broad Categories

Nanotechnology Nanoparticles Polymer & Macromolecule Science Noncoding RNA Drug Delivery Systems Nanofibers, Scaffolds & Fabrication

MeSH Descriptors

Nanomedicine

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

08
Manling Du, Fengjie Liu, Panpan Wang et al.
Purpose: To overcome dose-limiting toxicity and paclitaxel (PTX) resistance in triple-negative breast cancer (TNBC) therapy, as well as the asynchronous in vivo biodistribution of PTX and psoralen (PSO) combination regimens, we developed...
10
Shaoshi Ma, Yingying Wei, Borui Ma et al.
Purpose: To address the high recurrence rate of hepatocellular carcinoma (HCC) following microwave ablation (MWA) therapy, this study develops aluminum-europium metal-organic framework (AlEu MOF) nanoparticles that enhance MWA efficacy b...

Bibliographical & Catalog Notes

Description based on first issue; title from cover.

Latest issue consulted: v. 1, no. 3 (2006).

Print issues ceased with v. 4, no. 4 (2008).

Also issued online.

Issued by: Institute of Nanotechnology.